Clinical Trials Browser

Phase 2 × Endometrial Neoplasms × Cetuximab × Clear all

NCT00392769 2012-09-06

Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer

Phase 2 Completed

33 enrolled 5 charts

Endometrial Neoplasms